$ALGS 3 SEC Filings

Filed On	Filing
19 Feb 2026	Form 3: Aneja Nikhil, Principal Accounting Officer
26 Sep 2024	Form 3: Achneck Hardean, Chief Medical Officer No securities owned
09 Aug 2024	Form 3: Chavez Margarita, Director No securities owned
09 Aug 2024	Form 3: Preston Heather, Director No securities owned
07 Nov 2023	Form 3: Roche Holding Ltd, 10% owner and 1 other Holds 11,025,941 shares of Common Stock, par value $0.0001 per share
06 May 2022	Form 3: McClure Matthew W., Chief Medical Officer Holds 91,204 shares of Common Stock
18 Nov 2021	Form 3: Martell Bridget A, Director No securities owned
27 Apr 2021	Form 3: Scopa James Paul, Director No securities owned
15 Oct 2020	Form 3: Wellington Biomedical Innovation Master Investors (Cayman) I L.p., 10% owner
15 Oct 2020	Form 3: Novo Holdings A/S, 10% owner
15 Oct 2020	Form 3: Woiwode Thomas, Director
15 Oct 2020	Form 3: Vivo Capital VIII, Llc, 10% owner and 2 others
15 Oct 2020	Form 3: Versant Venture Capital VI, L.p., 10% owner and 1 other
15 Oct 2020	Form 3: Symons Julian A., See Remarks Holds 375,547 shares of Common Stock
15 Oct 2020	Form 3: Quan Lucinda Y., See Remarks Holds 375,547 shares of Common Stock
15 Oct 2020	Form 3: Nuechterlein Carole, Director
15 Oct 2020	Form 3: Nielsen Jack, Director No securities owned
15 Oct 2020	Form 3: Moldt Peter, Director No securities owned
15 Oct 2020	Form 3: Hirth Peter, Director Holds 59,549 shares of Common Stock
15 Oct 2020	Form 3: Glaub Kathleen Sereda, Director Holds 59,550 shares of Common Stock

Comments